Concurrent Paper Session II-Concurrent Paper Session II

Video Transcription

Video Summary

The video transcript is a summary of a concurrent paper session that included multiple presentations on different topics. The summary provides an overview of each presentation and highlights some key points. The first presentation discussed a pilot protocol for the treatment of methamphetamine use on inpatient units. The presenter discussed the growing problem of methamphetamine use and the need for a protocol to address it. The protocol involved comprehensive medical evaluations and the use of behavior-based orders to manage symptoms and promote recovery. The presenter discussed the positive impact of the protocol on reducing the duration of methamphetamine symptoms and improving treatment outcomes.<br /><br />The second presentation focused on the impact of COVID-19 on treatment outcomes in a cohort of individuals with opioid use disorder. The presenter discussed the increased risk of COVID-19 among individuals with substance use disorders and the poor outcomes associated with the virus. The study found that individuals with opioid use disorder and COVID-19 had high rates of ICU admission and the need for COVID-19 specific medications. The presenter emphasized the need for integrated care and evidence-based interventions for this population.<br /><br />The third presentation described a case series from an ongoing clinical trial of patients undergoing low dose or microdose buprenorphine transitions followed by administration of depo-buprenorphine. The presenter discussed the challenges of induction on buprenorphine for patients with high medical complexity and comorbidity, including pain disorders and concurrent opioid use. The presenter shared the results of the case series, which demonstrated the tolerability and effectiveness of the low dose transition strategy.<br /><br />The fourth presentation discussed a retrospective chart review of patients prescribed benzodiazepines in an outpatient psychiatry clinic. The presenter highlighted the lack of evidence-based or protocolized prescribing interventions for benzodiazepines in psychiatric care settings. The study found that a significant proportion of patients prescribed benzodiazepines had risk factors for adverse effects, such as older age, comorbid substance use disorders, and history of falls. The presenter emphasized the need for protocolized, evidence-based approaches to deprescribing benzodiazepines in psychiatric care settings.<br /><br />Overall, the presentations highlighted the importance of integrated care, evidence-based interventions, and protocolized approaches to improve treatment outcomes for individuals with substance use disorders and other psychiatric conditions.

Keywords

methamphetamine use

inpatient units

protocol

COVID-19

opioid use disorder

integrated care

evidence-based interventions

low dose buprenorphine transitions

benzodiazepines

improve treatment outcomes

	The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.		400 Massasoit Avenue Suite 108 East Providence, RI 02914 cmecpd@aaap.org Privacy	About Advocacy Membership Fellowship Education and Resources Training Events